UPDATED Apr 23, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LIN | US$445.06 | -0.4% | 21.9% | US$214.3b | US$472.41 | PE34.6x | E8.4% | 1.2% | ||
SCCO | US$109.64 | -4.0% | 45.2% | US$84.8b | US$82.12 | PE35x | E9.2% | 3.6% | ||
SHW | US$302.36 | -2.5% | 32.1% | US$76.8b | US$337.32 | PE31.8x | E7.8% | 0.9% | ||
FCX | US$47.99 | -3.7% | 28.7% | US$68.8b | US$50.82 | PE37.4x | E24.8% | 1.3% | ||
ECL | US$219.66 | 0.2% | 35.1% | US$62.8b | US$231.79 | PE45.8x | E14.1% | 1.0% | ||
CRH | US$78.79 | 0.3% | 64.7% | US$54.0b | US$93.21 | PE17.1x | E7.2% | 2.1% | ||
APD | US$233.71 | 2.1% | -18.2% | US$52.0b | US$269.58 | PE22.3x | E12.0% | 3.0% | ||
NEM | US$37.71 | -2.2% | -20.0% | US$43.5b | US$45.61 | PS3.7x | E42.4% | 2.7% | ||
NUE | US$174.64 | -9.4% | 20.9% | US$41.9b | US$202.71 | PE9.9x | E-9.3% | 1.2% | ||
DOW | US$56.74 | -0.1% | 7.9% | US$39.9b | US$59.57 | PE69x | E28.8% | 4.9% | ||
CTVA | US$55.18 | 3.1% | -7.5% | US$38.6b | US$62.45 | PE41.5x | E18.5% | 1.2% | ||
MLM | US$594.39 | 0.2% | 72.5% | US$36.7b | US$620.58 | PE30.6x | E7.6% | 0.5% | ||
VMC | US$259.34 | 0.4% | 55.6% | US$34.3b | US$281.96 | PE36.3x | E12.3% | 0.7% | ||
LYB | US$100.55 | 0.9% | 11.0% | US$32.7b | US$104.43 | PE15.5x | E12.5% | 5.0% | ||
AEM | US$62.92 | 0.7% | 12.6% | US$31.3b | US$70.74 | PE16.1x | E-5.4% | 2.5% | ||
DD | US$73.80 | 1.0% | 9.5% | US$30.9b | US$77.88 | PE62.5x | E29.0% | 2.1% | ||
PPG | US$130.43 | -3.4% | -5.2% | US$30.6b | US$157.15 | PE21.8x | E8.7% | 2.0% | ||
IFF | US$85.43 | 3.1% | -9.5% | US$21.8b | US$88.75 | PS1.9x | E72.1% | 1.9% | ||
STLD | US$134.16 | -3.4% | 31.3% | US$21.2b | US$130.89 | PE8.6x | E-14.4% | 1.4% | ||
BALL | US$65.50 | 2.4% | 27.8% | US$20.6b | US$66.35 | PE29.2x | E11.3% | 1.2% | ||
WLK | US$149.36 | 0.5% | 37.0% | US$19.2b | US$153.45 | PE40.3x | E29.3% | 1.3% | ||
RS | US$313.94 | -2.5% | 30.6% | US$18.0b | US$359.55 | PE13.5x | E-10.0% | 1.4% | ||
CE | US$156.05 | 1.0% | 55.3% | US$17.4b | US$162.00 | PE8.8x | E-7.9% | 1.8% | ||
AVY | US$211.33 | 1.2% | 28.0% | US$17.0b | US$222.33 | PE33.8x | E12.6% | 1.5% |